Education, Science, Technology, Innovation and Life
Open Access
Sign In

Effect of AI on GMP-Taking Quality Control in GMP as an Example

Download as PDF

DOI: 10.23977/jaip.2023.060302 | Downloads: 25 | Views: 497

Author(s)

Yiyi Shen 1

Affiliation(s)

1 East China University of Science and Technology, Shanghai 200237, China

Corresponding Author

Yiyi Shen

ABSTRACT

The Good Manufacturing Practice for Pharmaceutical Production (GMP) is a set of mandatory standards for pharmaceutical industries. GMP requires pharmaceutical manufacturers to strictly improve the quality management and verification system in accordance with the relevant national regulations, ensure the reliable process of pharmaceutical equipment, and realize the safe production of drugs. Under such a strict system, the excellence of GMP quality management system enables the small differences in all links of drug production to be found and corrected by the system, so as to ensure the quality, safety and effectiveness of drugs [1]. At present, modern science and technology has increasingly become an important basis for the research and development of new drugs. Among them, artificial intelligence (artificiAI intelligence, AI), as an advanced technological means, is bringing great promotion and change to many fields in GMP. Wikipedia's definition of artificial intelligence [2]: "Artificial intelligence, also called machine intelligence, is different from the natural intelligence of human beings themselves, which refers to the intelligence expressed by machines made by human beings". In recent years, AI technology has been widely used in various aspects of GMP, such as data processing, production line efficiency, and quality control, to improve the detection accuracy, efficiency, and management level. This paper will illustrate the impact of AI technology on GMP from the application, advantages, challenges and its future development prospects.

KEYWORDS

GMP Quality Control, AI technology, Safety Data, online Testing Equipment

CITE THIS PAPER

Yiyi Shen, Effect of AI on GMP-Taking Quality Control in GMP as an Example. Journal of Artificial Intelligence Practice (2023) Vol. 6: 8-14. DOI: http://dx.doi.org/10.23977/jaip.2023.060302.

REFERENCES

[1] Wu Chun, Li Huixia, Huang Xueya. Application of image recognition technology in drug managementsystem. Fujian Computer, 2020, 36(12):152-153.DOI:10.16707/j.cnki.fjpc. 2020.12.048.
[2] Wikipedia. Artificial intelligence [EB/OL]. [2019-12-21]. https: / /zh. wikipedia.org / wiki / artificial intelligence.
[3] Wu Qian, Liu Hao, Zhou Qiming. Development and application of visual real-time management and control system of network monitoring production process. Network Security and Informatization, 2022 (03): 79-81.
[4] Ma Zhichao. Application of dispatching system in the whole process of PVC production. Chinese chlor-alkali, 2022 (01): 27-30.
[5] Tian Chunhua, Xia Dongsheng, Liu Cuili, Gao Jianchao. Review of and existing problems in Adverse Drug Reactions. Pharmacovigilance, China, 2015, 12 (09): 531-533 + 537.
[6] Gao Song, Gao Yuejuan, Zhu Renying, Wang Lili, Xiu Yanli, Bi Linyu. Progress in the application of data mining technology in monitoring adverse drug reactions. Chinese Contemporary Medicine, 2021,28 (26): 31-35.
[7] Sun Jieyin, Wang Lejian, Wu Huifang, etc. Construction of drug risk monitoring index system based on data mining. Technology and Market, 2022, 29 (12): 141-145.
[8] Liang Gang, Gao Yin, Lai Hui, Zhou Yanchi, Yuan Yuan. Research on drug traceability system based on blockchain technology. China Pharmaceutical Economics, 2022, 17 (01): 9-13.
[9] Zhang Xinyue. Research on the development and application of artificial intelligence technology. Digital Communication World, 2022 (10): 133-135.
[10] Tang Jiliang. Automation and information technology, the pharmaceutical industry modernization is the only way. Automated Expo, 2014 (10): 52-57.
[11] Szarfman Ana, Tonning Joseph M, Levine Jonathan G,Doraiswamy P MurAIi. AtypicAI antipsychotics and pituitary tumors: a pharmacovigilance study. Pharmacotherapy, 2006, 26(6).
[12] Colman E, Szarfman A, Wyeth J, et AI. An AI evluation of a data mining sign AI for amyotrophic later AI sclerosis and statins detected in FDA's spontaneous adverse event reporting system. Pharmacoepidemiology and Drug Safety, 2008, 17(11):1068-1076.
[13] Rivkees S A, Szarfman A. Dissimilar Hepatotoxicity Profiles of Propylthiouracil and Methimazole in Children. The Journ AI of Clinic AI Endocrinology & Metabolism, 2010, 95(7):3260-3267.
[14] Madigan D, Shin J. Drospirenone-containing or AI contraceptives and venous thromboembolism: an AIysis of the FAERS database. 2018, Volume 9:29-32.

Downloads: 5963
Visits: 180466

Sponsors, Associates, and Links


All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.